Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE50.0000
- TODAY'S CHANGE (%)-2.8900 (-5.4642%)
- Bid / Lots49.9700/ 1
- Ask / Lots50.1900/ 2
- Open / Previous Close52.3300 / 52.8900
- Day Range
- 52 Week Range
- Volume141,604
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 1582 | 51.465 |
| 09:34 ET | 1091 | 51.515 |
| 09:36 ET | 200 | 51.51 |
| 09:38 ET | 312 | 51.05 |
| 09:39 ET | 1001 | 50.99 |
| 09:41 ET | 1023 | 50.5 |
| 09:43 ET | 500 | 50.795 |
| 09:45 ET | 805 | 50.82 |
| 09:50 ET | 100 | 50.67 |
| 09:52 ET | 400 | 50.77 |
| 09:54 ET | 1400 | 50.91 |
| 09:56 ET | 100 | 50.92 |
| 09:57 ET | 1354 | 51.0963 |
| 09:59 ET | 805 | 50.985 |
| 10:01 ET | 2712 | 50.81 |
| 10:03 ET | 3091 | 50.04 |
| 10:08 ET | 4229 | 49.8 |
| 10:10 ET | 100 | 49.875 |
| 10:12 ET | 804 | 49.48 |
| 10:14 ET | 1060 | 48.78 |
| 10:15 ET | 350 | 49 |
| 10:17 ET | 200 | 48.79 |
| 10:19 ET | 400 | 49 |
| 10:21 ET | 1800 | 49.32 |
| 10:26 ET | 922 | 49.35 |
| 10:28 ET | 100 | 49.7299 |
| 10:30 ET | 100 | 49.22 |
| 10:32 ET | 437 | 48.83 |
| 10:33 ET | 1948 | 48.76 |
| 10:35 ET | 300 | 48.625 |
| 10:37 ET | 4570 | 48.77 |
| 10:39 ET | 100 | 48.63 |
| 10:44 ET | 205 | 48.52 |
| 10:46 ET | 802 | 48.955 |
| 10:48 ET | 100 | 48.985 |
| 10:50 ET | 2722 | 48.68 |
| 10:51 ET | 200 | 48.845 |
| 10:53 ET | 272 | 48.845 |
| 10:57 ET | 200 | 48.68 |
| 11:00 ET | 100 | 48.685 |
| 11:02 ET | 100 | 48.63 |
| 11:04 ET | 380 | 48.5375 |
| 11:06 ET | 200 | 48.67 |
| 11:08 ET | 200 | 48.6575 |
| 11:09 ET | 350 | 48.705 |
| 11:11 ET | 700 | 48.995 |
| 11:18 ET | 100 | 48.76 |
| 11:20 ET | 100 | 49.16 |
| 11:22 ET | 415 | 49.09 |
| 11:24 ET | 100 | 49.23 |
| 11:26 ET | 700 | 49.315 |
| 11:27 ET | 700 | 49.6 |
| 11:29 ET | 200 | 49.7 |
| 11:31 ET | 329 | 49.74 |
| 11:33 ET | 200 | 49.75 |
| 11:36 ET | 100 | 49.73 |
| 11:38 ET | 529 | 49.66 |
| 11:42 ET | 200 | 49.49 |
| 11:44 ET | 840 | 49.385 |
| 11:47 ET | 300 | 49.25 |
| 11:49 ET | 1236 | 49.18 |
| 11:56 ET | 100 | 49.12 |
| 11:58 ET | 308 | 49.16 |
| 12:02 ET | 100 | 49.31 |
| 12:05 ET | 2926 | 49.25 |
| 12:07 ET | 100 | 49.39 |
| 12:12 ET | 600 | 49.455 |
| 12:14 ET | 400 | 49.625 |
| 12:18 ET | 1600 | 49.861 |
| 12:21 ET | 1511 | 50.095 |
| 12:23 ET | 500 | 50 |
| 12:34 ET | 2626 | 49.81 |
| 12:38 ET | 100 | 49.77 |
| 12:39 ET | 100 | 49.95 |
| 12:41 ET | 252 | 49.99 |
| 12:43 ET | 305 | 49.98 |
| 12:48 ET | 500 | 50.06 |
| 12:52 ET | 800 | 50 |
| 12:54 ET | 400 | 49.99 |
| 12:56 ET | 1335 | 49.88 |
| 12:57 ET | 1000 | 49.88 |
| 12:59 ET | 400 | 50 |
| 01:01 ET | 2195 | 49.93 |
| 01:06 ET | 1520 | 49.77 |
| 01:10 ET | 100 | 49.815 |
| 01:14 ET | 1130 | 49.8 |
| 01:17 ET | 230 | 49.793 |
| 01:19 ET | 2421 | 50 |
| 01:24 ET | 100 | 50.06 |
| 01:26 ET | 100 | 49.995 |
| 01:30 ET | 600 | 50.31 |
| 01:32 ET | 300 | 50.185 |
| 01:33 ET | 100 | 50.33 |
| 01:35 ET | 200 | 50.77 |
| 01:39 ET | 100 | 50.8099 |
| 01:42 ET | 700 | 50.46 |
| 01:46 ET | 200 | 50.355 |
| 01:48 ET | 200 | 50.28 |
| 01:50 ET | 336 | 50.2 |
| 01:55 ET | 200 | 50.23 |
| 01:57 ET | 1201 | 50.03 |
| 02:13 ET | 200 | 49.98 |
| 02:15 ET | 100 | 49.915 |
| 02:22 ET | 100 | 50.04 |
| 02:24 ET | 986 | 50.08 |
| 02:27 ET | 1535 | 50.08 |
| 02:29 ET | 383 | 49.9211 |
| 02:31 ET | 100 | 50.03 |
| 02:33 ET | 200 | 50.09 |
| 02:36 ET | 400 | 50.07 |
| 02:38 ET | 448 | 50.1 |
| 02:40 ET | 200 | 50.1 |
| 02:44 ET | 100 | 50.08 |
| 02:45 ET | 100 | 50.1 |
| 02:47 ET | 100 | 49.96 |
| 02:49 ET | 500 | 50.05 |
| 02:56 ET | 200 | 49.995 |
| 02:58 ET | 500 | 50.1 |
| 03:00 ET | 500 | 50.03 |
| 03:02 ET | 100 | 50.09 |
| 03:05 ET | 200 | 50.17 |
| 03:07 ET | 100 | 50.37 |
| 03:09 ET | 409 | 50.31 |
| 03:12 ET | 100 | 50.42 |
| 03:16 ET | 300 | 50.42 |
| 03:18 ET | 100 | 50.47 |
| 03:20 ET | 1700 | 50 |
| 03:21 ET | 200 | 50.025 |
| 03:23 ET | 400 | 50.17 |
| 03:25 ET | 1220 | 49.91 |
| 03:30 ET | 202 | 49.96 |
| 03:32 ET | 503 | 50 |
Jun 11, 2024
DJ Corbus Pharmaceuticals Is Maintained at Outperform by RBC Capital, from 8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
8:27AM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 3, 2024
DJ Corbus Pharmaceuticals Reaches 2-Year High After Drug Results, from 1:11PM ET on Monday Jun 03, 2024 by Dow Jones
1:11PM ET on Monday Jun 03, 2024 by Dow JonesDJ Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:33AM ET on Monday Jun 03, 2024 by Dow Jones
8:33AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024, from 10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
10:00AM ET on Saturday Jun 01, 2024 by Dow Jones
May 30, 2024
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones
8:00AM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 547.7M | -7.2x | --- |
Replimune Group Inc | 541.7M | -2.6x | --- |
Savara Inc | 558.3M | -10.6x | --- |
Allogene Therapeutics Inc | 535.5M | -1.3x | --- |
Oric Pharmaceuticals Inc | 532.6M | -4.1x | --- |
Mind Medicine (MindMed) Inc | 564.2M | -2.6x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Chairman of the Board
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $565.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.62 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -7.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
